These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
406 related items for PubMed ID: 19100368
41. Strategies for the treatment of recurrent acute lymphoblastic leukemia in adults. Bassan R, Lerede T, Barbui T. Haematologica; 1996; 81(1):20-36. PubMed ID: 8900848 [Abstract] [Full Text] [Related]
43. Risk-adapted stratification and treatment of childhood acute lymphoblastic leukaemia. Schrappe M. Radiat Prot Dosimetry; 2008 Apr 02; 132(2):130-3. PubMed ID: 19017727 [Abstract] [Full Text] [Related]
44. Acute lymphocytic leukemia in the adolescent: diagnosis, treatment, and outcomes. Dunsmore KP. Adolesc Med; 1999 Oct 02; 10(3):407-17, x-xi. PubMed ID: 10611938 [Abstract] [Full Text] [Related]
45. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, Chen YH, Zhang XH, Lu DP. Biol Blood Marrow Transplant; 2009 Feb 02; 15(2):257-65. PubMed ID: 19167686 [Abstract] [Full Text] [Related]
46. Long-term outcome of childhood acute lymphoblastic leukemia treated in China. Tang Y, Xu X, Song H, Yang S, Shi S, Wei J. Pediatr Blood Cancer; 2008 Sep 02; 51(3):380-6. PubMed ID: 18506765 [Abstract] [Full Text] [Related]
47. Continued complete remission without systemic therapy for isolated testicular relapse after bone marrow transplantation in a boy with acute lymphoblastic leukemia. Kodama Y, Okamoto Y, Ijichi O, Shinkoda Y, Nishikawa T, Tanabe T, Yoshioka T, Tashiro Y, Mougi H, Kawano Y. Pediatr Transplant; 2009 Sep 02; 13(6):769-72. PubMed ID: 19067929 [Abstract] [Full Text] [Related]
48. Prognostic value of early treatment response in children with acute lymphoblastic leukemia: a single institution experience in Shanghai, China. Tie LJ, Gu LJ, Song DL, Jiang LM, Xue HL, Tang JY, Dong L, Pan C, Chen J, Ye H, Chen J. Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan 02; 11(1):5-9. PubMed ID: 19149913 [Abstract] [Full Text] [Related]
50. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia. Lee S, Kim YJ, Chung NG, Lim J, Lee DG, Kim HJ, Min CK, Lee JW, Min WS, Kim CC. Cancer; 2009 Feb 01; 115(3):561-70. PubMed ID: 19117346 [Abstract] [Full Text] [Related]
51. Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse. Pulsipher MA, Bader P, Klingebiel T, Cooper LJ. Biol Blood Marrow Transplant; 2009 Jan 01; 15(1 Suppl):62-71. PubMed ID: 19147081 [Abstract] [Full Text] [Related]
52. Hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: a pediatric single center experience. Messina C, Cesaro S, Pillon M, Gazzola MV, Destro R, Calore E, Brugiolo A, Albergoni MP, Bovo D, Scarzello G, De Silvestro G, Marson P, Boso C, Volpato S, Varotto S, Petris MG, Zanesco L. Haematologica; 2002 Aug 01; 87(8 Suppl):20-3. PubMed ID: 12412385 [No Abstract] [Full Text] [Related]
53. Secondary intracranial neoplasms exhibiting features of astrocytoma and neuroblastoma in 2 children treated for acute lymphoblastic leukemia: report of 2 cases. Vancura RW, Kepes JJ, Newell KL, Ha TM, Arnold PM. Surg Neurol; 2006 May 01; 65(5):490-4. PubMed ID: 16630913 [Abstract] [Full Text] [Related]
54. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). Burke MJ, Cao Q, Trotz B, Weigel B, Kumar A, Smith A, Verneris MR. Pediatr Blood Cancer; 2009 Dec 15; 53(7):1289-94. PubMed ID: 19731318 [Abstract] [Full Text] [Related]
55. Differences in significance of drug resistance mechanisms between adult and childhood acute lymphoblastic leukemia. Styczyński J, Wysocki M. Haematologia (Budap); 2002 Dec 15; 32(4):313-25. PubMed ID: 12803106 [Abstract] [Full Text] [Related]
56. Understanding medication adherence in pediatric acute lymphoblastic leukemia: a review. Pritchard MT, Butow PN, Stevens MM, Duley JA. J Pediatr Hematol Oncol; 2006 Dec 15; 28(12):816-23. PubMed ID: 17164651 [Abstract] [Full Text] [Related]
57. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of acute lymphoblastic leukemia in children. ASBMT Executive Committee. Biol Blood Marrow Transplant; 2006 Mar 15; 12(3):370-1. PubMed ID: 16503508 [No Abstract] [Full Text] [Related]
58. [Recent advance in treatment of childhood acute lymphoblastic leukemia]. Watanabe A. Gan To Kagaku Ryoho; 2007 Feb 15; 34(2):150-5. PubMed ID: 17301519 [Abstract] [Full Text] [Related]
59. Genomic strategies to improve outcome and individualize therapy in cancer: the paradigm of childhood acute lymphoblastic leukemia. Kager L. J BUON; 2009 Sep 15; 14 Suppl 1():S181-6. PubMed ID: 19785064 [Abstract] [Full Text] [Related]
60. [Treatment of acute leukemia with allogeneic stem cell transplantation]. Seiwerth RS, Mrsić M, Nemet D, Bogdanić V, Mikulić M, Sertić D, Grković L, Cecuk E, Bojanić I, Batinić D, Labar B. Acta Med Croatica; 2009 Jun 15; 63(3):205-8. PubMed ID: 19827346 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]